Plegridy approved for NHS in Wales

Plegridy (peginterferon beta-1a) has been approved as a treatment for relapsing remitting multiple sclerosis on the NHS by the Welsh drug regulator the All Wales Medicines Strategy Group (AWMSG).
Source: Multiple Sclerosis Trust - Category: Neurology Source Type: news